Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report

Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report

Bibliographic Details
Main Authors:	Sabrina Khuder, Samantha Davis, Nathan Gilbert, Nezam Altorok
Format:	Article
Language:	English
Published:	The University of Toledo 2023-12-01
Series:	Translation
Subjects:	Interstitial lung disease mycophenolate mofetil autoimmune autoimmune diseases
Online Access:	https://openjournals.utoledo.edu/index.php/translation/article/view/934

Similar Items

Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
by: Douglas A. Simonetto, et al.
Published: (2018-05-01)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
by: Seung Woon Park, et al.
Published: (2016-06-01)

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies
by: C Bandelier
Published: (2009-01-01)

Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity
by: Rubén Berrueco, et al.
Published: (2023-10-01)

Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis
by: Mirjam Kolev, et al.
Published: (2022-01-01)

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
by: George N. Dalekos, et al.
Published: (2022-12-01)

Therapeutic efficacy and clinical effectiveness of mycophenolate mofetil and dexamethasone for immune thrombocytopenia: A retrospective observational study
by: Nilesh Wasekar, et al.
Published: (2021-01-01)

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients
by: George N. Dalekos, et al.
Published: (2022-01-01)

Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
by: Maria De Santis, et al.
Published: (2022-05-01)

Interstitial pneumonia with autoimmune features
by: Uma Karjigi, et al.
Published: (2021-01-01)

Mycophenolate therapy in interstitial pneumonia with autoimmune features: a cohort study
by: McCoy SS, et al.
Published: (2018-11-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Mycophenolate Mofetil Improves Exercise Tolerance in Systemic Sclerosis Patients with Interstitial Lung Disease: A Pilot Study
by: Valentina Vaiarello, et al.
Published: (2020-08-01)

A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids
by: Agnieszka Ewa Sieradzka, et al.
Published: (2022-07-01)

Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study
by: Farhad Handjani, et al.
Published: (2017-05-01)

Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review
by: Giulia Cassone, et al.
Published: (2021-01-01)

Mycophenolate Mofetil;A Review of Indications and Use in a Large Tertiary Hospital
by: Nimeshan Geevasinga, et al.
Published: (2005-12-01)

Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor
by: Dong Li, et al.
Published: (2023-07-01)

Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
by: Wang Pengfei, et al.
Published: (2023-11-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial
by: Anna E. C. Stoelinga, et al.
Published: (2024-01-01)

Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium
by: Kina Jeon, et al.
Published: (2022-08-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Successful Late Conversion to Mycophenolate Mofetil and Prednisone Immunosuppression Therapy in a Renal Transplant Recipient
by: Iqbal A, et al.
Published: (2000-01-01)

Management of erythema nodosum leprosum by mycophenolate mofetil
by: Banerjee Kalyan, et al.
Published: (2008-01-01)

Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review
by: Alice Tung Wan Song, et al.

Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study
by: Hanisch F, et al.
Published: (2009-08-01)

Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil
by: Mustafa Çakan, et al.
Published: (2019-10-01)

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
by: Romée J. A. L. M. Snijders, et al.
Published: (2022-12-01)

Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient
by: Einollahi Behzad, et al.
Published: (2015-04-01)

Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
by: Yichen Jia, et al.
Published: (2018-07-01)

Duodenal villous atrophy caused by Mycophenolate Mofetil in patients with solid organ transplantation: case report
by: Giuston Mendoza-Chuctaya, et al.
Published: (2016-03-01)

Evaluation of neutropenia secondary to mycophenolate mofetil associated with valganciclovir in liver transplant patients
by: Alejandro Ferrer-Machín, et al.
Published: (2021-03-01)

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant
by: Natalia Oleksik, et al.
Published: (2022-10-01)

Mycophenolate Mofetil-Induced Segmental Colitis Mimicking Ischemic Colitis
by: Kevin Johal, et al.
Published: (2014-03-01)

Mycophenolate mofetil in giant cell arteritis
by: Anne Pankow, et al.
Published: (2023-11-01)

Mycophenolate mofetil for the treatment of warm autoimmune haemolytic anaemia post-rituximab therapy: a case series
by: Oscar F. Borja-Montes, et al.
Published: (2024-08-01)

Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: recent insights
by: Ali SAHIN
Published: (2010-05-01)

Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
by: Minoo Moghimi, et al.
Published: (2021-12-01)